Healis Therapeutics announces collaboration with Massachusetts General Hospital (MGH) and affiliates of Harvard Medical School to advance clinical-stage neuroscience research
26 mars 2024 08h00 HE
|
Healis Therapeutics
The collaboration will focus on Healis’ clinical program studying the safety and efficacy of CKDB-501A, a BoNT/A neuromodulator, for neuropsychiatry.
Precision Neuroscience Expands Clinical Research In Brain–Computer Interface
22 mars 2024 08h30 HE
|
Precision Neuroscience
NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced the launch of two new clinical study sites, at...
Biomaterials Market Sale to hit US$ 470 Billion by 2032 and expand at a CAGR of 14.5%, says Persistence Market Research
21 févr. 2023 10h20 HE
|
Persistence Market Research
New York, Feb. 21, 2023 (GLOBE NEWSWIRE) -- The global Biomaterials Market was valued at US$ 112 Billion in 2021 and is expected to reach US$ 470 Billion by 2032. The global market for biomaterials...
NeuroSigma Announces that Enrollment Commences in Two Large, Double-Blind Trials of eTNS for Pediatric ADHD
08 nov. 2022 10h00 HE
|
NeuroSigma, Inc.
Trials recruiting subjects at UCLA and Seattle Children’s Hospital in the United States, and at King’s College London and the University of Southampton in the United Kingdom Trials sponsored by the...
Neurorehabilitation Devices Market Value Anticipated To Reach US$ 3,476.3 Million By 2027: Acumen Research and Consulting
05 févr. 2021 11h02 HE
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Neurorehabilitation Devices Market– Global Industry Analysis, Market Size,...
Karamedica Announces National Institute on Aging Grant to Continue Development of Microparticle Therapy for Cerebral Amyloid Angiopathy
15 déc. 2020 07h55 HE
|
Karamedica, Inc.
RALEIGH, N.C., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Karamedica, Inc. recently received a $2.5 million Small Business Innovative Research (SBIR) Phase II grant from the National Institute on Aging to...
Grey Cloak Tech Inc. Releases Independent Report
20 oct. 2020 08h30 HE
|
Grey Cloak Tech Inc.
LAS VEGAS, Oct. 20, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Grey Cloak Tech Inc. (OTC: GRCK) (soon to be Healthy Extracts Inc. pending a corporate name change), a company engaged in proprietary...
Naboso™ Technology Announces Acceptance into Startup Incubator Program with Upward Labs
15 oct. 2019 10h10 HE
|
Naboso Technology
NEW YORK, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Naboso™ Technology, a leading proprioceptive insole and mat company, announces its acceptance into Upward Labs, a unique pilot and accelerator program...
Naboso™ Technology Announces Partnership with Xero Shoes, Bringing First Barefoot Proprioceptive Sandals to Market
22 juil. 2019 09h00 HE
|
Naboso Technology
NEW YORK, July 22, 2019 (GLOBE NEWSWIRE) -- Naboso™ Technology, creator of the first commercially available proprioceptive insoles and mats, announces today its collaboration with Xero Shoes, a...
Naboso™ Technology and TrueForm Runner Launch the First and Only Proprioceptive Treadmill for Rehabilitation and Performance
17 juin 2019 10h55 HE
|
Naboso Technology
NEW YORK, June 17, 2019 (GLOBE NEWSWIRE) -- A patent-pending textured material developed by Naboso™ Technology, a leading proprioceptive insole and mat company, is now being used in combination with...